Hao Microbiology is a developer of vascular interventional embolization products.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 15, 2022 | Series A | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Guangzhou Guofa Venture Capital | — | Series A |